These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28391793)

  • 1. Imaging in Multiple Sclerosis: Diagnosis and Management.
    Mukherji SK
    Neuroimaging Clin N Am; 2017 May; 27(2):xv. PubMed ID: 28391793
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in the Diagnosis, Characterization, and Monitoring of Multiple Sclerosis.
    Rovira À
    Neuroimaging Clin N Am; 2017 May; 27(2):xvii-xviii. PubMed ID: 28391794
    [No Abstract]   [Full Text] [Related]  

  • 3. Standardizing Magnetic Resonance Imaging Protocols, Requisitions, and Reports in Multiple Sclerosis: An Update for Radiologist Based on 2017 Magnetic Resonance Imaging in Multiple Sclerosis and 2018 Consortium of Multiple Sclerosis Centers Consensus Guidelines.
    Arevalo O; Riascos R; Rabiei P; Kamali A; Nelson F
    J Comput Assist Tomogr; 2019; 43(1):1-12. PubMed ID: 30015803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI differential diagnosis of suspected multiple sclerosis.
    Chen JJ; Carletti F; Young V; Mckean D; Quaghebeur G
    Clin Radiol; 2016 Sep; 71(9):815-27. PubMed ID: 27349475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-high-field (7.0 Tesla and above) MRI is now necessary to make the next step forward in understanding MS pathophysiology - NO.
    Jonkman L
    Mult Scler; 2017 Mar; 23(3):374-375. PubMed ID: 28260417
    [No Abstract]   [Full Text] [Related]  

  • 6. Whole-brain T1-relaxation time measurements in multiple sclerosis.
    Barkhof F
    J Neurol; 2002 Oct; 249(10):1451-2. PubMed ID: 12532927
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiologically Isolated Syndrome: MR Imaging Features Suggestive of Multiple Sclerosis Prior to First Symptom Onset.
    Okuda DT
    Neuroimaging Clin N Am; 2017 May; 27(2):267-275. PubMed ID: 28391785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain and Spinal Cord MR Imaging Features in Multiple Sclerosis and Variants.
    Dekker I; Wattjes MP
    Neuroimaging Clin N Am; 2017 May; 27(2):205-227. PubMed ID: 28391782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-high-field (7.0 Tesla and above) MRI is now necessary to make the next step forward in understanding MS pathophysiology - YES.
    Bagnato F; Gore JC
    Mult Scler; 2017 Mar; 23(3):372-373. PubMed ID: 28260420
    [No Abstract]   [Full Text] [Related]  

  • 10. The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.
    Mahajan KR; Ontaneda D
    Neurotherapeutics; 2017 Oct; 14(4):905-923. PubMed ID: 28770481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Pathology in Multiple Sclerosis with High-Field-Strength MR Spectroscopic Imaging.
    Barker PB
    Radiology; 2022 Apr; 303(1):151-152. PubMed ID: 34981980
    [No Abstract]   [Full Text] [Related]  

  • 12. Brain Atrophy in Multiple Sclerosis: Clinical Relevance and Technical Aspects.
    Sastre-Garriga J; Pareto D; Rovira À
    Neuroimaging Clin N Am; 2017 May; 27(2):289-300. PubMed ID: 28391787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis in childhood: clinical and radiological features.
    Forrester MB; Coleman L; Kornberg AJ
    J Child Neurol; 2009 Jan; 24(1):56-62. PubMed ID: 18940915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Multiple Sclerosis.
    Kumar A; Aggarwal V
    Indian Pediatr; 2016 Nov; 53(11):1028-1029. PubMed ID: 27889740
    [No Abstract]   [Full Text] [Related]  

  • 15. A level set method for multiple sclerosis lesion segmentation.
    Zhao Y; Guo S; Luo M; Shi X; Bilello M; Zhang S; Li C
    Magn Reson Imaging; 2018 Jun; 49():94-100. PubMed ID: 28522366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardization of MRI data and disability quantification in the post-EPIC era.
    Avasarala J
    CNS Spectr; 2018 Feb; 23(1):8-9. PubMed ID: 28179041
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach.
    Uher T; Vaneckova M; Sormani MP; Krasensky J; Sobisek L; Dusankova JB; Seidl Z; Havrdova E; Kalincik T; Benedict RH; Horakova D
    Eur J Neurol; 2017 Feb; 24(2):292-301. PubMed ID: 27873386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Pediatric Multiple Sclerosis-Challenges and Recent Advances.
    Parmar K; Banwell BL; Akbar N; Bigi S
    Neuropediatrics; 2018 Jun; 49(3):165-172. PubMed ID: 29482255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of blood brain barrier using DCE MRI in multiple sclerosis - Technical issues and its possible role in routine clinical practice.
    Gupta RK
    Neurol India; 2018; 66(3):671-672. PubMed ID: 29766921
    [No Abstract]   [Full Text] [Related]  

  • 20. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.